MARKET WIRE NEWS

NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-12 21:50:30 ET

NeuroPace, Inc. (NPCE)

Q2 2025 Earnings Conference Call

August 12, 2025 04:30 PM ET

Company Participants

Joel D. Becker - CEO, President & Director

Patrick F. Williams - Chief Financial Officer

Conference Call Participants

Frank James Takkinen - Lake Street Capital Markets, LLC, Research Division

Priya Sachdeva - UBS Investment Bank, Research Division

Rohin Kirit Patel - JPMorgan Chase & Co, Research Division

Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division

Vikramjeet Singh Chopra - Wells Fargo Securities, LLC, Research Division

Yi Chen - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Ladies and gentlemen, greetings, and welcome to the NeuroPace, Inc. Second Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Scott Schaper, Head of Investor Relations at NeuroPace, Inc. Please go ahead.

Unidentified Company Representative

Good afternoon. Thank you for joining us for NeuroPace's Second Quarter 2025 Financial and Operating Results Conference Call. On today's call, we will hear from Joel Becker, Chief Executive Officer; and Patrick Williams, Chief Financial Officer....

Read the full article on Seeking Alpha

For further details see:

NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript
Neuropace Inc.

NASDAQ: NPCE

NPCE Trading

-3.3% G/L:

$13.94 Last:

86,320 Volume:

$14.34 Open:

mwn-app Ad 300

NPCE Latest News

NPCE Stock Data

$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App